ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 55 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $726,379 | +123.8% | 102,741 | +191.3% | 0.00% | – |
| Q4 2023 | $324,520 | +100.1% | 35,274 | +31.6% | 0.00% | – |
| Q3 2023 | $162,195 | -83.6% | 26,809 | -84.5% | 0.00% | – |
| Q1 2023 | $987,006 | +789.2% | 173,159 | +730.9% | 0.00% | – |
| Q1 2022 | $111,000 | -82.8% | 20,840 | +8.8% | 0.00% | – |
| Q2 2020 | $646,000 | – | 19,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 496,893 | $16,760,000 | 14.90% |
| Svennilson Peter | 4,768,181 | $160,831,000 | 13.45% |
| Invus Financial Advisors, LLC | 1,007,576 | $33,986,000 | 12.28% |
| EcoR1 Capital, LLC | 2,642,218 | $89,122,000 | 6.58% |
| Foresite Capital Management IV, LLC | 125,000 | $4,216,000 | 2.05% |
| Orbimed Advisors | 2,921,967 | $98,558,000 | 1.39% |
| Casdin Capital, LLC | 251,515 | $8,484,000 | 0.50% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 191,568 | $6,462,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 300,000 | $10,119,000 | 0.30% |
| EMERALD ADVISERS, LLC | 186,140 | $6,279,000 | 0.27% |